These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 443652)

  • 1. A case of maturity-onset diabetes mellitus resistant to insulin but responsive to tolbutamide.
    Rendell M; Slevin D; Meltz G; Simpson J; Barquet A
    Ann Intern Med; 1979 Feb; 90(2):195-7. PubMed ID: 443652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A comparison of intravenous tolbutamide and insulin administration during and after operation in patients with maturity-onset diabetes (author's transl)].
    Fähndrich W; Liebermeister H; Schmitt H; Daweke H
    Dtsch Med Wochenschr; 1974 Jan; 99(4):121-7. PubMed ID: 4203796
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of long-term tolbutamide treatment on glucose tolerance and insulin secretion in maturity-onset diabetes without obesity.
    Lauvaux JP; Mandart G; Heymans G; Ooms HA
    Horm Metab Res; 1972 Mar; 4(2):58-62. PubMed ID: 5028221
    [No Abstract]   [Full Text] [Related]  

  • 4. Exacerbation of diabetes mellitus by antibodies to exogenous insulin.
    Rendell M; Hamilton RG; Drew HM; Adkinson NF
    Am J Med Sci; 1981; 282(1):18-26. PubMed ID: 7270568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An evaluation of secondary failure to tolbutamide therapy.
    Jerums G; Ennis GC; Miller M
    Aust N Z J Med; 1974 Oct; 4(5):467-74. PubMed ID: 4616676
    [No Abstract]   [Full Text] [Related]  

  • 6. [Serum immunoreactive insulin after the oral administration of single dose of tolbutamide. I. Peripheral vein immunoreactive insulin in normal subjects and mild diabetics (author's transl)].
    Goto A
    Nihon Naibunpi Gakkai Zasshi; 1975 Aug; 51(8):676-84. PubMed ID: 1237421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glipizide versus tolbutamide, an open trial. Effects on insulin secretory patterns and glucose concentrations.
    Fineberg SE; Schneider SH
    Diabetologia; 1980 Jan; 18(1):49-54. PubMed ID: 6988265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous tolbutamide adminisration in the control of diabetes during operation.
    Schmitt H; Liebermeister H; Lo Sardo G; Daweke H
    Ger Med Mon; 1969 Sep; 14(9):444-9. PubMed ID: 5352296
    [No Abstract]   [Full Text] [Related]  

  • 9. Diabetes mellitus. Distinguishing between patients receiving insulin and those requiring insulin therapy.
    Mahler RJ
    West J Med; 1974 May; 120(5):358-62. PubMed ID: 4839480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor depletion in diabetes mellitus: correction with therapy.
    Eaton RP; Galagan R; Kaufman E; Allen RC; Russell L; Miller F
    Diabetes Care; 1981; 4(2):299-304. PubMed ID: 7011748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of tolbutamide and chloramphenicol in diabetic patients.
    Brunová E; Slabochová Z; Platilová H; Pavlik F; Grafnetterová J; Dvorácek K
    Int J Clin Pharmacol Biopharm; 1977 Jan; 15(1):7-12. PubMed ID: 838527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of control of blood glucose on plasma insulin responses to various stimuli in secondary failures to oral hypoglycemic agents and in newly diagnosed, maturity onset, ketosis-resistant diabetics.
    Schmeltz R; Wendorff HJ; Field JB
    J Clin Endocrinol Metab; 1978 Apr; 46(4):519-27. PubMed ID: 755038
    [No Abstract]   [Full Text] [Related]  

  • 13. [Evaluation of therapy of diabetes mellitus, with special reference to the control of diabetes mellitus with oral antidiabetics].
    Kadota I
    Nihon Rinsho; 1969 Aug; 27(8):2136-50. PubMed ID: 4901777
    [No Abstract]   [Full Text] [Related]  

  • 14. Hypoglycemic and hypotriglyceridemic effects of tolbutamide in triphenyltin chloride-induced diabetic rabbits.
    Watanabe M; Watanabe K; Matsui H
    Vet Hum Toxicol; 2002 Jun; 44(3):140-4. PubMed ID: 12046964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of short-term clofibrate on glucose metabolism and insulin secretion in patients with mild maturity-onset diabetes mellitus.
    Ferrari C; Romussi M; Bertazzoni A; Testori GP; Grimaldi MG
    Biomedicine; 1978 Jun; 29(4):133-6. PubMed ID: 556385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pre-, intra- and postoperative control of metabolism in diabetic patients using intravenous doses of tolbutamide].
    Bauch K; Dempe A; Hartig W; Ruttloff J
    Zentralbl Chir; 1974 Jan; 99(3):82-6. PubMed ID: 4458335
    [No Abstract]   [Full Text] [Related]  

  • 17. Differential effects of tolbutamide on first and second phase insulin secretion in noninsulin-dependent diabetes mellitus.
    Pfeifer MA; Halter JB; Beard JC; Porte D
    J Clin Endocrinol Metab; 1981 Dec; 53(6):1256-62. PubMed ID: 7028776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of tolbutamide on plasma catecholamine in insulin dependent diabetics.
    Sato T; Miura Y; Saito T; Ito M; Kokubun M; Sakuma H; Adachi M; Yoshinaga K
    Tohoku J Exp Med; 1979 Jan; 127(1):97-8. PubMed ID: 760255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of propranolol on the hypoglycemic action of insulin and tolbutamide in diabetic patients].
    Kowalski S; Wolański A
    Pol Arch Med Wewn; 1969; 42(1):55-61. PubMed ID: 5767511
    [No Abstract]   [Full Text] [Related]  

  • 20. [Diminution of delay in insulin secretion in early diabetes mellitus with ongoing tolbutamide treatment].
    Nadeau A; Catellier C
    Union Med Can; 1974 Mar; 103(3):413-7. PubMed ID: 4820869
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.